Marwan Sabbagh, MD, FAAN
Professor of Neurology
Alzheimer s and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Marwan Sabbagh, MD, FAAN: consultant/advisor/speaker: Alzheon, Biogen, Eisai, Genentech-Roche, KeifeRx, Lilly, NeuroTherapia, Novo Nordisk, Signant Health, Synaptogenix, T3D; ownership interest (stocks/stock options): Athira, Cortexyme/Quince Therapeutics, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, Seq BioMarque, TransDermix, uMethod Health, Versanum; royalties or patent beneficiary: Humanix.